Santa Cruz Biotechnology provides a broad selection of HSV-2 ICP10 monoclonal antibodies for advanced research in virology and immunology. HSV-2 ICP10 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HSV-2 ICP10 plays a critical role in the viral life cycle, acting as a key factor in the replication and pathogenesis of herpes simplex virus type 2. Understanding the function of HSV-2 ICP10 is essential for developing therapeutic strategies and vaccines against herpesvirus infections. Research focused on HSV-2 ICP10 contributes to the broader knowledge of viral mechanisms and host interactions. Scientists can leverage HSV-2 ICP10 monoclonal antibodies to investigate viral protein expression patterns and cellular localization. Examining HSV-2 ICP10 interactions with host proteins reveals important insights into viral infection mechanisms. Researchers studying viral pathogenesis can utilize HSV-2 ICP10 monoclonal antibodies to track protein dynamics during different stages of infection. Santa Cruz Biotechnology monoclonal antibodies for HSV-2 ICP10 support researchers worldwide in advancing scientific understanding of herpesvirus biology and potential therapeutic approaches.